1 Ruxolitinib Market Overview 1.1 Ruxolitinib Product Overview 1.2 Ruxolitinib Market Segment by Type 1.2.1 5mg Tablets 1.2.2 10mg Tablets 1.2.3 15mg Tablets 1.2.4 20mg Tablets 1.3 Global Ruxolitinib Market Size by Type 1.3.1 Global Ruxolitinib Market Size Overview by Type (2016-2027) 1.3.2 Global Ruxolitinib Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Ruxolitinib Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Ruxolitinib Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Ruxolitinib Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Ruxolitinib Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Ruxolitinib Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Ruxolitinib Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Ruxolitinib Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Ruxolitinib Sales Breakdown by Type (2016-2021) 1.4.2 Europe Ruxolitinib Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Ruxolitinib Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Ruxolitinib Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Ruxolitinib Sales Breakdown by Type (2016-2021) 2 Global Ruxolitinib Market Competition by Company 2.1 Global Top Players by Ruxolitinib Sales (2016-2021) 2.2 Global Top Players by Ruxolitinib Revenue (2016-2021) 2.3 Global Top Players Ruxolitinib Price (2016-2021) 2.4 Global Top Manufacturers Ruxolitinib Manufacturing Base Distribution, Sales Area, Product Type 2.5 Ruxolitinib Market Competitive Situation and Trends 2.5.1 Ruxolitinib Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Ruxolitinib Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ruxolitinib as of 2020) 2.7 Date of Key Manufacturers Enter into Ruxolitinib Market 2.8 Key Manufacturers Ruxolitinib Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Ruxolitinib Status and Outlook by Region 3.1 Global Ruxolitinib Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Ruxolitinib Historic Market Size by Region 3.2.1 Global Ruxolitinib Sales in Volume by Region (2016-2021) 3.2.2 Global Ruxolitinib Sales in Value by Region (2016-2021) 3.2.3 Global Ruxolitinib Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Ruxolitinib Forecasted Market Size by Region 3.3.1 Global Ruxolitinib Sales in Volume by Region (2022-2027) 3.3.2 Global Ruxolitinib Sales in Value by Region (2022-2027) 3.3.3 Global Ruxolitinib Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Ruxolitinib by Application 4.1 Ruxolitinib Market Segment by Application 4.1.1 Moderate Myelofibrosis 4.1.2 High Risk Myelofibrosis 4.1.3 Polycythemia Vera 4.1.4 Other 4.2 Global Ruxolitinib Market Size by Application 4.2.1 Global Ruxolitinib Market Size Overview by Application (2016-2027) 4.2.2 Global Ruxolitinib Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Ruxolitinib Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Ruxolitinib Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Ruxolitinib Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Ruxolitinib Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Ruxolitinib Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Ruxolitinib Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Ruxolitinib Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Ruxolitinib Sales Breakdown by Application (2016-2021) 4.3.2 Europe Ruxolitinib Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Ruxolitinib Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Ruxolitinib Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Ruxolitinib Sales Breakdown by Application (2016-2021) 5 North America Ruxolitinib by Country 5.1 North America Ruxolitinib Historic Market Size by Country 5.1.1 North America Ruxolitinib Sales in Volume by Country (2016-2021) 5.1.2 North America Ruxolitinib Sales in Value by Country (2016-2021) 5.2 North America Ruxolitinib Forecasted Market Size by Country 5.2.1 North America Ruxolitinib Sales in Volume by Country (2022-2027) 5.2.2 North America Ruxolitinib Sales in Value by Country (2022-2027) 6 Europe Ruxolitinib by Country 6.1 Europe Ruxolitinib Historic Market Size by Country 6.1.1 Europe Ruxolitinib Sales in Volume by Country (2016-2021) 6.1.2 Europe Ruxolitinib Sales in Value by Country (2016-2021) 6.2 Europe Ruxolitinib Forecasted Market Size by Country 6.2.1 Europe Ruxolitinib Sales in Volume by Country (2022-2027) 6.2.2 Europe Ruxolitinib Sales in Value by Country (2022-2027) 7 Asia-Pacific Ruxolitinib by Region 7.1 Asia-Pacific Ruxolitinib Historic Market Size by Region 7.1.1 Asia-Pacific Ruxolitinib Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Ruxolitinib Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Ruxolitinib Forecasted Market Size by Region 7.2.1 Asia-Pacific Ruxolitinib Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Ruxolitinib Sales in Value by Region (2022-2027) 8 Latin America Ruxolitinib by Country 8.1 Latin America Ruxolitinib Historic Market Size by Country 8.1.1 Latin America Ruxolitinib Sales in Volume by Country (2016-2021) 8.1.2 Latin America Ruxolitinib Sales in Value by Country (2016-2021) 8.2 Latin America Ruxolitinib Forecasted Market Size by Country 8.2.1 Latin America Ruxolitinib Sales in Volume by Country (2022-2027) 8.2.2 Latin America Ruxolitinib Sales in Value by Country (2022-2027) 9 Middle East and Africa Ruxolitinib by Country 9.1 Middle East and Africa Ruxolitinib Historic Market Size by Country 9.1.1 Middle East and Africa Ruxolitinib Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Ruxolitinib Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Ruxolitinib Forecasted Market Size by Country 9.2.1 Middle East and Africa Ruxolitinib Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Ruxolitinib Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Ruxolitinib Business 10.1 Novartis 10.1.1 Novartis Corporation Information 10.1.2 Novartis Introduction and Business Overview 10.1.3 Novartis Ruxolitinib Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Novartis Ruxolitinib Products Offered 10.1.5 Novartis Recent Development 10.2 Shandong Chuangxin Pharmaceutical Research and Development 10.2.1 Shandong Chuangxin Pharmaceutical Research and Development Corporation Information 10.2.2 Shandong Chuangxin Pharmaceutical Research and Development Introduction and Business Overview 10.2.3 Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Novartis Ruxolitinib Products Offered 10.2.5 Shandong Chuangxin Pharmaceutical Research and Development Recent Development 10.3 Orifarm AS 10.3.1 Orifarm AS Corporation Information 10.3.2 Orifarm AS Introduction and Business Overview 10.3.3 Orifarm AS Ruxolitinib Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Orifarm AS Ruxolitinib Products Offered 10.3.5 Orifarm AS Recent Development 10.4 Incyte Corporation 10.4.1 Incyte Corporation Corporation Information 10.4.2 Incyte Corporation Introduction and Business Overview 10.4.3 Incyte Corporation Ruxolitinib Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Incyte Corporation Ruxolitinib Products Offered 10.4.5 Incyte Corporation Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Ruxolitinib Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Ruxolitinib Industrial Chain Analysis 11.4 Ruxolitinib Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Ruxolitinib Distributors 12.3 Ruxolitinib Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 5mg Tablets Table 2. Major Company of 10mg Tablets Table 3. Major Company of 15mg Tablets Table 4. Major Company of 20mg Tablets Table 5. Global Ruxolitinib Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Ruxolitinib Sales by Type (2016-2021) & (K Pcs) Table 7. Global Ruxolitinib Sales Market Share in Volume by Type (2016-2021) Table 8. Global Ruxolitinib Sales by Type (2016-2021) & (US& Million) Table 9. Global Ruxolitinib Market Share in Value by Type (2016-2021) Table 10. Global Ruxolitinib Price by Type (2016-2021) & (USD/Pcs) Table 11. Global Ruxolitinib Sales by Type (2022-2027) & (K Pcs) Table 12. Global Ruxolitinib Sales Market Share in Volume by Type (2022-2027) Table 13. Global Ruxolitinib Sales by Type (2022-2027) & (US$ Million) Table 14. Global Ruxolitinib Sales Market Share in Value by Type (2022-2027) Table 15. Global Ruxolitinib Price by Type (2022-2027) & (USD/Pcs) Table 16. North America Ruxolitinib Sales by Type (2016-2021) & (K Pcs) Table 17. North America Ruxolitinib Sales by Type (2016-2021) & (US$ Million) Table 18. Europe Ruxolitinib Sales (K Pcs) by Type (2016-2021) Table 19. Europe Ruxolitinib Sales by Type (2016-2021) & (US$ Million) Table 20. Asia-Pacific Ruxolitinib Sales (K Pcs) by Type (2016-2021) Table 21. Asia-Pacific Ruxolitinib Sales by Type (2016-2021) & (US$ Million) Table 22. Latin America Ruxolitinib Sales (K Pcs) by Type (2016-2021) Table 23. Latin America Ruxolitinib Sales by Type (2016-2021) & (US$ Million) Table 24. Middle East and Africa Ruxolitinib Sales (K Pcs) by Type (2016-2021) Table 25. Middle East and Africa Ruxolitinib Sales by Type (2016-2021) & (US$ Million) Table 26. Global Ruxolitinib Sales by Company (2016-2021) & (K Pcs) Table 27. Global Ruxolitinib Sales Share by Company (2016-2021) Table 28. Global Ruxolitinib Revenue by Company (2016-2021) & (US$ Million) Table 29. Global Ruxolitinib Revenue Share by Company (2016-2021) Table 30. Global Market Ruxolitinib Price by Company (2016-2021) & (USD/Pcs) Table 31. Global Ruxolitinib Top Manufacturers Manufacturing Base Distribution and Sales Area Table 32. Global Ruxolitinib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ruxolitinib as of 2020 Table 34. Date of Key Manufacturers Enter into Ruxolitinib Market Table 35. Key Manufacturers Ruxolitinib Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Ruxolitinib Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 38. Global Ruxolitinib Sales by Region (2016-2021) & (K Pcs) Table 39. Global Ruxolitinib Sales Market Share in Volume by Region (2016-2021) Table 40. Global Ruxolitinib Sales by Region (2016-2021) & (US$ Million) Table 41. Global Ruxolitinib Sales Market Share in Value by Region (2016-2021) Table 42. Global Ruxolitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 43. Global Ruxolitinib Sales by Region (2022-2027) & (K Pcs) Table 44. Global Ruxolitinib Sales Market Share in Volume by Region (2022-2027) Table 45. Global Ruxolitinib Sales by Region (2022-2027) & (US$ Million) Table 46. Global Ruxolitinib Sales Market Share in Value by Region (2022-2027) Table 47. Global Ruxolitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 48. Global Ruxolitinib Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 49. Global Ruxolitinib Sales by Application (2016-2021) & (K Pcs) Table 50. Global Ruxolitinib Sales Market Share in Volume by Application (2016-2021) Table 51. Global Ruxolitinib Sales by Application (2016-2021) & (US$ Million) Table 52. Global Ruxolitinib Sales Market Share in Value by Application (2016-2021) Table 53. Global Ruxolitinib Price by Application (2016-2021) & (USD/Pcs) Table 54. Global Ruxolitinib Sales by Application (2022-2027) & (K Pcs) Table 55. Global Ruxolitinib Sales Market Share in Volume by Application (2022-2027) Table 56. Global Ruxolitinib Sales by Application (2022-2027) & (US$ Million) Table 57. Global Ruxolitinib Sales Market Share in Value by Application (2022-2027) Table 58. Global Ruxolitinib Price by Application (2022-2027) & (USD/Pcs) Table 59. North America Ruxolitinib Sales by Application (2016-2021) (K Pcs) Table 60. North America Ruxolitinib Sales by Application (2016-2021) & (US$ Million) Table 61. North America Ruxolitinib Sales Market Share in Value by Application in 2020 Table 62. Europe Ruxolitinib Sales by Application (2016-2021) (K Pcs) Table 63. Europe Ruxolitinib Sales by Application (2016-2021) & (US$ Million) Table 64. Europe Ruxolitinib Sales Market Share in Value by Application in 2020 Table 65. Asia-Pacific Ruxolitinib Sales by Application (2016-2021) (K Pcs) Table 66. Asia-Pacific Ruxolitinib Sales by Application (2016-2021) & (US$ Million) Table 67. Asia-Pacific Ruxolitinib Sales Market Share in Value by Application in 2020 Table 68. Latin America Ruxolitinib Sales by Application (2016-2021) (K Pcs) Table 69. Latin America Ruxolitinib Sales by Application (2016-2021) & (US$ Million) Table 70. Latin America Ruxolitinib Sales Market Share in Value by Application in 2020 Table 71. Middle East and Africa Ruxolitinib Sales by Application (2016-2021) (K Pcs) Table 72. Middle East and Africa Ruxolitinib Sales by Application (2016-2021) & (US$ Million) Table 73. Middle East and Africa Ruxolitinib Sales Market Share in Value by Application in 2020 Table 74. North America Ruxolitinib Sales by Country (2016-2021) & (K Pcs) Table 75. North America Ruxolitinib Sales Market Share in Volume by Country (2016-2021) Table 76. North America Ruxolitinib Sales by Country (2016-2021) & (US$ Million) Table 77. North America Ruxolitinib Sales Market Share in Value by Country (2016-2021) Table 78. North America Ruxolitinib Sales by Country (2022-2027) & (K Pcs) Table 79. North America Ruxolitinib Sales Market Share in Volume by Country (2022-2027) Table 80. North America Ruxolitinib Sales by Country (2022-2027) & (US$ Million) Table 81. North America Ruxolitinib Sales Market Share in Value by Country (2022-2027) Table 82. Europe Ruxolitinib Sales by Country (2016-2021) & (K Pcs) Table 83. Europe Ruxolitinib Sales Market Share in Volume by Country (2016-2021) Table 84. Europe Ruxolitinib Sales by Country (2016-2021) & (US$ Million) Table 85. Europe Ruxolitinib Sales Market Share in Value by Country (2016-2021) Table 86. Europe Ruxolitinib Sales by Country (2022-2027) & (K Pcs) Table 87. Europe Ruxolitinib Sales Market Share in Volume by Country (2022-2027) Table 88. Europe Ruxolitinib Sales by Country (2022-2027) & (US$ Million) Table 89. Europe Ruxolitinib Sales Market Share in Value by Country (2022-2027) Table 90. Asia-Pacific Ruxolitinib Sales by Region (2016-2021) & (K Pcs) Table 91. Asia-Pacific Ruxolitinib Sales Market Share in Volume by Region (2016-2021) Table 92. Asia-Pacific Ruxolitinib Sales by Region (2016-2021) & (US$ Million) Table 93. Asia-Pacific Ruxolitinib Sales Market Share in Value by Region (2016-2021) Table 94. Asia-Pacific Ruxolitinib Sales by Region (2022-2027) & (K Pcs) Table 95. Asia-Pacific Ruxolitinib Sales Market Share in Volume by Region (2022-2027) Table 96. Asia-Pacific Ruxolitinib Sales by Region (2022-2027) & (US$ Million) Table 97. Asia-Pacific Ruxolitinib Sales Market Share in Value by Region (2022-2027) Table 98. Latin America Ruxolitinib Sales by Country (2016-2021) & (K Pcs) Table 99. Latin America Ruxolitinib Sales Market Share in Volume by Country (2016-2021) Table 100. Latin America Ruxolitinib Sales by Country (2016-2021) & (US$ Million) Table 101. Latin America Ruxolitinib Sales Market Share in Value by Country (2016-2021) Table 102. Latin America Ruxolitinib Sales by Country (2022-2027) & (K Pcs) Table 103. Latin America Ruxolitinib Sales Market Share in Volume by Country (2022-2027) Table 104. Latin America Ruxolitinib Sales by Country (2022-2027) & (US$ Million) Table 105. Latin America Ruxolitinib Sales Market Share in Value by Country (2022-2027) Table 106. Middle East and Africa Ruxolitinib Sales by Country (2016-2021) & (K Pcs) Table 107. Middle East and Africa Ruxolitinib Sales Market Share in Volume by Country (2016-2021) Table 108. Middle East and Africa Ruxolitinib Sales by Country (2016-2021) & (US$ Million) Table 109. Middle East and Africa Ruxolitinib Sales Market Share in Value by Country (2016-2021) Table 110. Middle East and Africa Ruxolitinib Sales by Country (2022-2027) & (K Pcs) Table 111. Middle East and Africa Ruxolitinib Sales Market Share in Volume by Country (2022-2027) Table 112. Middle East and Africa Ruxolitinib Sales by Country (2022-2027) & (US$ Million) Table 113. Middle East and Africa Ruxolitinib Sales Market Share in Value by Country (2022-2027) Table 114. Novartis Corporation Information Table 115. Novartis Introduction and Business Overview Table 116. Novartis Ruxolitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 117. Novartis Ruxolitinib Product Table 118. Novartis Recent Development Table 119. Shandong Chuangxin Pharmaceutical Research and Development Corporation Information Table 120. Shandong Chuangxin Pharmaceutical Research and Development Introduction and Business Overview Table 121. Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 122. Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Product Table 123. Shandong Chuangxin Pharmaceutical Research and Development Recent Development Table 124. Orifarm AS Corporation Information Table 125. Orifarm AS Introduction and Business Overview Table 126. Orifarm AS Ruxolitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 127. Orifarm AS Ruxolitinib Product Table 128. Orifarm AS Recent Development Table 129. Incyte Corporation Corporation Information Table 130. Incyte Corporation Introduction and Business Overview Table 131. Incyte Corporation Ruxolitinib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 132. Incyte Corporation Ruxolitinib Product Table 133. Incyte Corporation Recent Development Table 134. Key Raw Materials Lists Table 135. Raw Materials Key Suppliers Lists Table 136. Ruxolitinib Market Trends Table 137. Ruxolitinib Market Drivers Table 138. Ruxolitinib Market Challenges Table 139. Ruxolitinib Market Restraints Table 140. Ruxolitinib Distributors List Table 141. Ruxolitinib Downstream Customers Table 142. Research Programs/Design for This Report Table 143. Key Data Information from Secondary Sources Table 144. Key Data Information from Primary Sources List of Figures Figure 1. Ruxolitinib Product Picture Figure 2. Global Ruxolitinib Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Ruxolitinib Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Ruxolitinib Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 5mg Tablets Figure 6. Global 5mg Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 10mg Tablets Figure 8. Global 10mg Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Product Picture of 15mg Tablets Figure 10. Global 15mg Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 11. Product Picture of 20mg Tablets Figure 12. Global 20mg Tablets Sales YoY Growth (2016-2021) & (K Pcs) Figure 13. Global Ruxolitinib Sales by Type (2016-2027) & (US$ Million) Figure 14. Global Ruxolitinib Sales Market Share in Volume by Type (2016-2021) Figure 15. Global Ruxolitinib Sales Market Share in Value by Type (2016-2021) Figure 16. Global Ruxolitinib Sales Market Share in Volume by Type (2022-2027) Figure 17. Global Ruxolitinib Sales Market Share in Value by Type (2022-2027) Figure 18. North America Ruxolitinib Sales Market Share in Volume by Type in 2020 Figure 19. North America Ruxolitinib Sales Market Share in Value by Type in 2020 Figure 20. Europe Ruxolitinib Sales Market Share in Volume by Type in 2020 Figure 21. Europe Ruxolitinib Sales Market Share in Value by Type in 2020 Figure 22. Asia-Pacific Ruxolitinib Sales Market Share in Volume by Type in 2020 Figure 23. Asia-Pacific Ruxolitinib Sales Market Share in Value by Type in 2020 Figure 24. Latin America Ruxolitinib Sales Market Share in Volume by Type in 2020 Figure 25. Latin America Ruxolitinib Sales Market Share in Value by Type in 2020 Figure 26. Middle East and Africa Ruxolitinib Sales Market Share in Volume by Type in 2020 Figure 27. Middle East and Africa Ruxolitinib Sales Market Share in Value by Type in 2020 Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Ruxolitinib Sales in 2020 Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Ruxolitinib Revenue in 2020 Figure 30. Ruxolitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Product Picture of Moderate Myelofibrosis Figure 32. Global Moderate Myelofibrosis Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of High Risk Myelofibrosis Figure 34. Global High Risk Myelofibrosis Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Product Picture of Polycythemia Vera Figure 36. Global Polycythemia Vera Sales YoY Growth (2016-2027) & (K Pcs) Figure 37. Product Picture of Other Figure 38. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 39. Global Ruxolitinib Sales by Application (2016-2027) & (US$ Million) Figure 40. Global Ruxolitinib Sales Market Share in Volume by Application (2016-2021) Figure 41. Global Ruxolitinib Sales Market Share in Value by Application (2016-2021) Figure 42. Global Ruxolitinib Sales Market Share in Volume by Application (2022-2027) Figure 43. North America Ruxolitinib Sales Market Share in Volume by Application in 2020 Figure 44. Latin America Ruxolitinib Sales Market Share in Value by Application in 2020 Figure 45. Middle East and Africa Ruxolitinib Sales Market Share in Value by Application in 2020 Figure 46. Key Raw Materials Price Figure 47. Ruxolitinib Manufacturing Cost Structure Figure 48. Ruxolitinib Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Novartis Shandong Chuangxin Pharmaceutical Research and Development Orifarm AS Incyte Corporation